Walgreens Boots Alliance, Inc. (WBA)
NEGATIVEFondamental
~0
Prix
$-
Capitalisation boursière
-
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Aucune description disponible.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Données financières limitées disponibles (0% des indicateurs). Les scores peuvent ne pas refléter fidèlement les fondamentaux de cette entreprise.
Bilan & Liquidités
Chiffre d'affaires
-
Résultat net
-
Flux de trésorerie libre
-
Capitaux propres totaux
-
Passif total
-
Ratio de liquidité général
0.68
Couverture des intérêts
-
Dette/EBITDA
-
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Indicateurs de valorisation
Ratio P/E
-
ROE
-72.7%
Ratio P/B
-
P/FCF
-
Marge brute
-
ROIC
-
Radar de rentabilité
Value Creation (Economic Moat)
ROIC
-
WACC
8.0%
ROIC − WACC
-
Critères d'analyse fondamentale
Réussi (0)
Échoué (0)
Indisponible (1)
- Error fetching data
Score F de Piotroski
Préoccupations financières sérieuses
Qualité des bénéfices
Qualité faible : examiner la comptabilité
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Gouvernance
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Latest News
Recent headlines for WBA, sourced from Markets Gazette.
- 6/9/2026NEUTRALBoots Owner in Talks on Possible $10 Billion Sale, FT Says
Walgreens Boots Alliance, the parent company of the UK health and beauty retailer Boots, is reportedly in discussions for a potential sale valued at approximately $10 billion. The Financial Times reports that potential suitors include the Weston family and Australian pharmacy group Sigma Healthcare Ltd. This news indicates a significant strategic move by WBA, potentially reshaping its portfolio. Investors will monitor the progress of these talks, as a sale could unlock value or signal a divestment of a key, albeit underperforming, asset.
- 4/2/2026POSITIVEWalgreens’ Private Equity Owner Plans to Double Pharmacy Chain’s Profits
The private equity owner of Walgreens has outlined ambitious plans to double the pharmacy chain's profitability within the coming years, following a substantial $10 billion acquisition. This strategic initiative, revealed by sources close to the deal, signals a strong conviction in Walgreens' turnaround potential. Investors will be closely watching the execution of these plans, which are expected to focus on operational efficiencies and market expansion. The news suggests a potential upside for the company's valuation, pending successful implementation of the private equity firm's growth strategy.
- 2/23/2026NEGATIVEWalgreens widens job cuts amid store closures
Walgreens Boots Alliance is escalating its restructuring efforts, announcing a new wave of job cuts and significant store closures. This action is part of a broader trend of distress within the U.S. retail pharmacy sector, highlighted by similar moves from competitors like CVS, which has laid off workers to focus on online delivery, and the bankruptcy of Rite Aid. Walgreens' strategy aims to cut costs and streamline its physical footprint to navigate a rapidly changing market and intense competitive pressure. Investors are closely watching to see if these drastic measures will be enough to reverse the negative trend and set the company back on a path to sustainable growth, amidst a landscape also marked by store closures from giants like Amazon.
via Markets Gazette